Technical Analysis for TIL - Instil Bio, Inc.

Grade Last Price % Change Price Change
F 0.85 -6.44% -0.06
TIL closed down 6.44 percent on Wednesday, February 8, 2023, on 56 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
MACD Bullish Centerline Cross Bullish -6.44%
Upper Bollinger Band Walk Strength -6.44%
Weak + Overbought Other -6.44%
Gapped Up Strength -6.44%
Overbought Stochastic Strength -6.44%
Upper Bollinger Band Touch Strength -6.44%
Upper Bollinger Band Walk Strength -6.85%
Weak + Overbought Other -6.85%
Wide Bands Range Expansion -6.85%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below 10 DMA about 8 hours ago
10 DMA Support about 8 hours ago
Fell Below Previous Day's Low about 8 hours ago
Down 5% about 10 hours ago
60 Minute Opening Range Breakdown about 11 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Oncology Cancer Immunotherapy Cell Therapy Non Small Cell Lung Cancer Melanoma Lymphocytes Cervical Cancer Head And Neck Squamous Cell Carcinoma Squamous Cell Carcinoma Cutaneous Squamous Cell Carcinoma Therapies For The Treatment Of Patients With Cancer Tumor Infiltrating Lymphocytes

Is TIL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.01
52 Week Low 0.471
Average Volume 1,757,628
200-Day Moving Average 4.18
50-Day Moving Average 0.80
20-Day Moving Average 0.81
10-Day Moving Average 0.85
Average True Range 0.08
RSI 50.25
ADX 25.71
+DI 21.38
-DI 14.15
Chandelier Exit (Long, 3 ATRs) 0.70
Chandelier Exit (Short, 3 ATRs) 0.87
Upper Bollinger Bands 0.92
Lower Bollinger Band 0.70
Percent B (%b) 0.67
BandWidth 27.16
MACD Line 0.00
MACD Signal Line -0.03
MACD Histogram 0.0281
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.96
Resistance 3 (R3) 0.97 0.94 0.94
Resistance 2 (R2) 0.94 0.91 0.94 0.94
Resistance 1 (R1) 0.89 0.89 0.88 0.88 0.93
Pivot Point 0.86 0.86 0.85 0.86 0.86
Support 1 (S1) 0.81 0.83 0.80 0.81 0.76
Support 2 (S2) 0.78 0.81 0.78 0.75
Support 3 (S3) 0.73 0.78 0.75
Support 4 (S4) 0.73